Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy.

Seok Jong Chung Tae-Yong Lee Yang Hyun Lee Kyoungwon Baik Jin Ho Jung Han Soo Yoo Chang Jae Shim Hyo Jin Eom Ji-Yeon Hong Dong Joon Kim Young H Sohn Phil Hyu Lee

Published in: Stem cells international (2021)

The present study confirmed that a single intra-arterial administration of autologous BM-MSCs is a safe and promising neuroprotective strategy in patients with MSA-C.

Keyphrases

bone marrow
mesenchymal stem cells
cell therapy
clinical trial
study protocol
umbilical cord
phase iii
stem cells
randomized controlled trial
phase ii
blood brain barrier
open label
brain injury